BX Financial Statements & Analysis
Complete financial statements for BX including income statement, balance sheet, and cash flow statement. Analyze BX's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
64
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
52.9% ↑
Net Income
99.6% ↑
Gross Margin
2.0% ↑
Operating Margin
42.8% ↑
Balance Sheet
Current Ratio
227391763320.0% ↑
Debt to Equity
-17.0% ↑
Asset Turnover
41.7% ↑
Cash Flow
Operating Cash Flow
-14.2% ↓
Net Cash Flow
10.3% ↑
Free Cash Flow
-10.8% ↓
Cash Flow to Debt
-14.1% ↓
Income Statement Comparison
Revenue & Net Income
Period Comparison
Metric | 2023 | 2024 | Change | Impact |
---|---|---|---|---|
Revenue | 7.44B | 11.37B | 52.9% | |
Gross Profit | 7.01B | 10.93B | 56.0% | |
Operating Income | 2.96B | 6.46B | 118.4% | |
Net Income | 1.39B | 2.78B | 99.6% | |
EPS | 1.84 | 3.62 | 96.7% | |
EBITDA | 3.00B | 6.50B | 116.7% | |
Gross Margin | 94.19% | 96.10% | 2.0% | |
Operating Margin | 39.76% | 56.79% | 42.8% | |
Net Income Margin | 18.70% | 24.41% | 30.5% | |
R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 11.37B | 7.44B | 7.45B | 16.85B | 5.40B |
Gross Profit | 10.93B | 7.01B | 7.13B | 16.65B | 5.23B |
Operating Income | 6.46B | 2.96B | 3.46B | 13.56B | 2.62B |
Net Income | 2.78B | 1.39B | 1.75B | 5.86B | 1.05B |
EPS | 3.62 | 1.84 | 2.36 | 8.14 | 1.5 |
EBITDA | 6.50B | 3.00B | 3.53B | 13.63B | 2.69B |
Gross Margin | 96.10% | 94.19% | 95.74% | 98.82% | 96.92% |
Operating Margin | 56.79% | 39.76% | 46.47% | 80.47% | 48.48% |
Net Income Margin | 24.41% | 18.70% | 23.46% | 34.76% | 19.36% |
R&D Expenses | 0 | 0 | 0 | 0 | 0 |